Search results
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly - Altimmune (NASDAQ:ALT), Amgen...
Benzinga· 4 days agoThe obesity market has garnered much interest lately, ever since Novo Nordisk NVO received FDA...
American exceptionalism on full display in financial markets … or is it?
The Washington Times· 7 days agoThe U.S. economy has confounded forecasters’ dour predictions, but not the optimism of financial...